CDMO Almac Group has held a groundbreaking ceremony for a $65 million expansion project on its North American headquarters campus in Souderton, Pennsylvania. This comes just after the company announced record breaking financial results and confirmed that its global workforce has reached 7,000.
Levaco Chemicals, a manufacturer of speciality chemicals and additives based at Chempark Leverkusen in Germany, has completed setting up a commcercial subsidiary in Brazil. The creation of a sales and logistics hub there “is already in full swing”, the company said.
Levaco, a Lanxess and Tanatex spin-off, has been already been active for several years in Brazil and sees particularly strong potential in the agrochemicals and food chemicals sectors. It has now installed a warehouse in São Paolo in order to guarantee imports and make deliveries more efficiently.
CRO Inotiv has completed the sale of its business in Israel, which it described as part of the site optimisation plan for its Research Models & Services segment that it launched last year. The buyer was not named. Further assets remain for sale, which have been closed as part of the process.
Amyris and some of its US domestic subsidiaries have begun voluntary Chapter 11 proceedings in the US Bankruptcy Court for the District of Delaware as part of an operational and financial restructuring. This process does not affect its subsidiaries outside the USA.
ICL has held the groundbreaking ceremony for a $400 million, 13,000 m2, 30,000 tones/year battery materials manufacturing facility at its Carondolet site at St Louis, Missouri. Present at the event on 8 August were Secretary of Energy Jennifer M. Granholm, whose department granted $197 million towards building the facility under the Investing in America agenda, and Missouri governor Mike Parson.
Minafin, owner of Minakem, Pennakem, Minagro and related brands, has revealed that it acquired Montréal-based Delmar in July. Terms were not disclosed. Delmar’s site, which will be rebranded Minafin Montréal, employs 100 and is approved by the US FDA and other regulatory agencies for API manufacture
Kemira president and CEO Jari Rosendal died after a short illness on 31 July. He was 58. The company had announced that he had gone on sick leave on 11 July and a week later said that he would step down by 2024 at the latest. CFO Petri Castrén is acting as interim president and CEO while a successor is sought.
